Sipuleucel-T: An Autologous Cellular Immunotherapy for Patients with Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

/ By Maria Relaki / Therapeutic Vaccines / 2 comments